Application of simulated fasting diet in the prevention and treatment of Parkinson's disease
A Parkinson's disease, heat technology, applied in the field of medical neurology, can solve the problems of PD mice with no therapeutic effect, worsening dysfunction, and low operability, and achieve the increase in the number of tyrosine hydroxylase-positive neuron cells , Improve the symptoms of slow movement, improve the effect of dopamine content
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2022-08-09
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the application of simulated fasting diet in preventing and treating Parkinson's disease, and belongs to the technical field of medical neurology. Background technique
[0002] Parkinson's disease (PD) is the most common degenerative disease of the motor nervous system. The main clinical manifestations are: resting tremor, bradykinesia, unsteadiness, postural reflex disorders, and non-motor symptoms such as dysbacteriosis and constipation. The main lesions in the brain of PD patients are the substantia nigra and striatum. The degeneration and death of dopaminergic (DA) neurons in the substantia nigra pars compacta is the direct cause of the decrease in dopamine projection into the striatum. The pathogenesis of PD is still unclear, but a large number of studies have shown that its occurrence interacts with pathological mechanisms such as oxidative stress injury, immune inflammation, apoptosis, and autophagy. Recent studies have ...
Examples
Embodiment 1
[0032] Example 1: Establishment and grouping of animal models
[0033] Body weight 20-25g, 7-week-old, male C57BL / 6J mice were randomly divided into blank control group (NS-AL group, ad libitum and intraperitoneal injection of normal saline), blank diet group (NS-FMD group, simulated fasting diet and Intraperitoneal injection of normal saline), model group (MPTP-AL group, free feeding and intraperitoneal injection of MPTP), treatment group (MPTP-FMD group, simulated fasting diet and intraperitoneal injection of MPTP), 20 animals in each group. The animals were placed at 23±2°C, and the lighting time was 12 hours / day, and the animals were acclimated to the environment for one week before dietary intervention. The NS-FMD group and the MPTP-FMD group were given FMD diet for three consecutive weeks, and on the last day of the second week, 0.9% saline or MPTP were injected intraperitoneally with MPTP (20 mg / kg) for four consecutive times, each time interval 2 hours. Both the NS-AL...